TRUMP EVENT SPECIAL

Glavna informacija

  • Trgovački naziv:
  • TRUMP EVENT SPECIAL
  • Koristi za:
  • Ljudi
  • Vrsta lijekova:
  • Medicinski uređaj

Dokument

  • za javnost:
  • Informativni letak za ovaj proizvod trenutno nije dostupan, možete poslati zahtjev na našu službu za korisnike, a mi ćemo vas obavijestiti čim smo u mogućnosti da ga dobiju.


    Zatražite informativni letak za javnost.

Lokalizacija

  • Na raspolaganju u:
  • TRUMP EVENT SPECIAL
    Hrvatska
  • Jezik:
  • hrvatski

Druge informacije

Status

  • Izvor:
  • Ecolab
  • Broj odobrenja:
  • 113293E
  • Zadnje ažuriranje:
  • 12-03-2018

Sažetak Opisa Svojstava

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br.

1907/2006

Trump Event (Special)

113293E

1 / 12

ODJELJAK 1. IDENTIFIKACIJA TVARI/SMJESE I PODACI O TVRTKI/PODUZEĆU

1.1 Identifikacijska oznaka proizvoda

Ime proizvoda

Trump Event (Special)

Oznaka proizvoda

113293E

Uporaba tvari/pripravka

Sredstvo za strojno pranje posuđa

Vrsta tvari

Smjesa

Samo za profesionalne korisnike.

Informacije o razrijeđenom

proizvodu

Nema informacija za razrijeđenje

1.2 Odgovarajuće identificirane namjene tvari ili smjese i namjene koje se ne preporučuju

Identificirane uporabe

Sredstvo za pranje i ispiranje u perilicama posuđa/automatski

postupak

Preporučena ograničenja u

svezi s uporabom

Ograničeno za industrijsku i profesionalnu uporabu.

1.3 Podaci o dobavljaču koji isporučuje sigurnosno-tehnički list

Proizvođač

Ecolab d.o.o.

Zavrtnica 17

10 000, Zagreb Hrvatska 01 632 1600 (radno vrijeme 8-16 h)

dijana.kovacic@ecolab.com

1.4 Broj telefona službe za izvanredna stanja

Broj telefona službe za

izvanredna stanja

Broj telefona za medicinske

informacije:

01-23-48-342 (Medicinske Info)

Datum sakupljanja/revizije

29.06.2016

Verzija

ODJELJAK 2. IDENTIFIKACIJA OPASNOSTI

2.1 Razvrstavanje tvari i smjese

Razvrstavanje (prema uredbi (EZ) br. 1272/2008 (CLP))

Nagriz. koža, Klasa 1A

H314

Ozljeda oka, klasa 1

H318

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

2 / 12

2.2 Elementi označivanja prema Direktivi 1999/45/EZ ili Uredbi (EZ) br. 1272/2008 (CLP)

Označivanje naljepnicom (prema uredbi (EZ) br. 1272/2008 (CLP))

Piktogrami opasnosti

Oznaka opasnosti

Opasnost

Oznake upozorenja

H314

Uzrokuje teške opekline kože i ozljede oka.

Oznake obavijesti

Sprječavanje:

P280

Nosite zaštitne rukavice/ zaštitu za oči/ zaštitu

za lice.

Postupanje:

P303 + P361 + P353

U SLUČAJU DODIRA S KOŽOM (ili

kosom): odmah skinuti svu zagađenu odjeću.

Isprati kožu vodom/tuširanjem.

P305 + P351 + P338

U SLUČAJU DODIRA S OČIMA: oprezno

ispirati vodom nekoliko minuta. Ukloniti

kontaktne leće ukoliko ih nosite i ako se one

lako uklanjaju. Nastaviti ispiranje.

P310

Odmah nazvati CENTAR ZA KONTROLU

OTROVANJA/liječnika.

Opasne tvari koje se moraju navesti na naljepnici:

sodium hydroxide

2.3 Ostale opasnosti

Nisu poznati.

ODJELJAK 3. SASTAV/INFORMACIJE O SASTOJCIMA

3.2 Smjese

Opasni sastojci

Kemijski naziv

CAS-br.

EZ-br.

Br. REACH

Razvrstavanjeprema uredbi (EZ) br.

1272/2008 (CLP)

Koncentracija:

sodium hydroxide

1310-73-2

215-185-5

01-2119457892-27

Nagriz. koža Klasa 1A; H314

Nagriz .met. klasa 1; H290

>= 10 - < 20

alanine, n,n-

bis(carboxymethyl)-,

trisodium salt

164462-16-2

01-0000016977-53

Nadraž. koža Klasa 2; H315

Nadražaj očiju Klasa 2; H319

>= 3 - < 5

Za puni tekst H-izjava navedenih u ovom odjeljku pogledajte odjeljak 16.

ODJELJAK 4. MJERE PRVE POMOĆI

4.1 Opis mjera prve pomoći

U slučaju dodira s očima

Odmah početi ispirati s puno vode, također ispod očnih kapaka, u

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

3 / 12

trajanju od najmanje 15 minuta. Ukloniti kontaktne leće ako ih

nosite i ako se one lako uklanjaju. Nastaviti ispiranje. Odmah

pozovite liječnika.

U slučaju dodira s kožom

Odmah ispirati s mnogo vode u trajanju od barem 15 minuta. Ako

je moguće, upotrijebiti blag sapun. Operite kontaminiranu odjeću

prije ponovne rabe. Prije ponovne uporabe, temeljito očistiti

obuću. Odmah pozovite liječnika.

U slučaju gutanja

Isprati usta vodom. NE izazivajte povraćanje. Nikada ne davati

bilo što u usta nesvjesnoj osobi. Odmah pozovite liječnika.

U slučaju inhalacije

Premjestiti na svjež zrak. Liječiti simptomatski. Ako se pojave

simptomi, potražiti liječničku pomoć.

4.2 Najvažniji simptomi i učinci, akutni i odgođeni

Vidjeti odjeljak 11 za detaljnije informacije o utjecajima na zdravlje i mogućim simptomima.

4.3 Navod o slučaju potrebe za hitnom liječničkom pomoći i posebnom obradom

Liječenje

Liječiti simptomatski.

ODJELJAK 5. MJERE GAŠENJA POŽARA

5.1 Sredstva za gašenje

Prikladna sredstva za

gašenje

Upotrijebiti mjere suzbijanja požara koje odgovaraju lokalnim

okolnostima i okolnom ambijentu.

Neprikladna sredstva za

gašenje požara

Nisu poznati.

5.2 Posebne opasnosti koje proizlaze iz tvari ili smjese

Posebne opasnosti tijekom

suzbijanja požara

Nije zapaljivo niti lako zapaljivo.

Opasni proizvodi izgaranja

Produkti raspadanja mogu uključivati sljedeće materijale:

ugljikovi oksidi

Dušikovi oksidi (NOx)

sumporni oksidi

Fosforovi oksidi

5.3 Savjeti za gasitelje požara

Posebna zaštitna oprema za

vatrogasce

: Koristiti osobnu zaštitnu opremu.

Dodatni podaci

: S požarnim ostacima i vodom koja se koristila za gašenje požara

mora se rukovati u skladu s lokalnim uredbama. U slučaju požara

i/ili eksplozije, ne udisati dimove.

ODJELJAK 6. MJERE KOD SLUČAJNOG ISPUŠTANJA

6.1 Osobne mjere opreza, zaštitna oprema i postupci za izvanredna stanja

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

4 / 12

Savjet za osoblje koje ne

intervenira u hitnim

slučajevima

Osigurati odgovarajuću ventilaciju. Držati ljude podalje i nasuprot

vjetru u odnosu na prolivenu tekućinu/pukotinu iz koje curi.

Izbjegavati udisanje, gutanje i dodir s kožom te očima. Ukoliko se

radnici susreću s količinama većim od graničnih vrijednosti

izloženosti, moraju koristiti odgovarajuće provjerene respiratore.

Osigurajte da čišcenje obavlja samo stručno osoblje. Pogledati

mjere zaštite navedene u odsjecima 7 i 8.

Savjet za osoblje koje

intervenira u hitnim

slučajevima

Ako je specijalizirana odjeća potrebna za rješavanje izlijevanja,

treba obratiti pažnju na bilo kakve informacije u Odjeljku 8 o

prikladnim i neprikladnim materijalima.

6.2 Mjere zaštite okoliša

Mjere zaštite okoliša

Ne dozvolite dodir s tlom, površinskim ili podzemnim vodama.

6.3 Metode i materijal za sprečavanje širenja i čišćenje

Metodama čišćenja

Ako je sigurno, zaustaviti istjecanje.Zaustavite i počistite prolivenu

tvar negorivim materijalom koji ima dobru moć upijanja (npr.

pijesak, zemlja, dijatomejska zemlja, vermikulit) te stavite u

spremnik za odlaganje prema lokalnim/nacionalnim uredbama

(pogledati odsjek 13).Isperite tragove vodom.Za velike izljeve

omeđiti proliveni materijal ili pokupiti materijal kako bi se osiguralo

da ne dospije u odvod.

6.4 Uputa za druge odjeljke

Vidjeti Odjeljak 1 za konakt za hitne informacije.

Za osobnu zaštitu pogledati odsjek 8.

Vidjeti Odjeljak 13 za dodatne informacije o zbrinjavanju otpada.

ODJELJAK 7. RUKOVANJE I SKLADIŠTENJE

7.1 Mjere opreza za sigurno rukovanje

Savjeti za sigurno rukovanje

Nemojte konzumirati. Spriječiti dodir s očima, kožom ili odjećom.

Ne udisati prašinu/dim/plin/maglu/pare/aerosol. Rabiti samo uz

odgovarajuću ventilaciju. Nakon uporabe temeljito oprati ruke

Higijenske mjere

Rukovati u skladu s važećom industrijskom higijenom i

sigurnosnom praksom. Skinuti i oprati kontaminiranu odjeću prije

ponovnog korištenja. Nakon rukovanja temeljito oprati lice, ruke i

izloženu kožu. Osigurati odgovarajući prostor za brzo namakanje

ili ispiranje očiju i tijela u slučaju kontakta ili prskanja opasnim

kemikalijama

7.2 Uvijeti sigurnog skladištenja, uzimajući u obzir moguće inkompatibilnosti

Uvjeti skladišnih prostora i

spremnika

Ne skladištiti blizu kiselina. Čuvati izvan dohvata djece. Čuvati u

dobro zatvorenom spremniku. Pohranjujte u primjerenim

obilježenim spremnicima.

Temperatura skladištenja

0 °C do 40 °C

7.3 Posebna krajnja uporaba ili uporabe

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

5 / 12

Posebna uporaba

Sredstvo za pranje i ispiranje u perilicama posuđa/automatski

postupak

ODJELJAK 8. NADZOR NAD IZLOŽENOŠĆU/OSOBNA ZAŠTITA

8.1 Nadzorni parametri

Ograničenja kod profesionalnog izlaganja

Sastojci

CAS-br.

Vrsta vrijednosti

(Oblik izloženosti)

Nadzorni parametri

Temelj

sodium hydroxide

1310-73-2

KGVI

2 mg/m3

HR OEL

Dodatni podaci

NAGRIZAJUĆE

DNEL

Natrijev hidroksid

Konačna upotreba: Radnici

Načini izloženosti: Inhalacija

Potencijalni učinci na zdravlje: Dugoročni lokalni učinci

Vrijednost: 1 mg/m3

Konačna upotreba: Potrošači

Načini izloženosti: Inhalacija

Potencijalni učinci na zdravlje: Dugoročni lokalni učinci

Vrijednost: 1 mg/m3

8.2 Nadzor nad izloženošću

Odgovarajući inženjerski mehanizmi

Tehničke mjere

Djelotvoran odvodno ventilacijski sustav. Održavati vrijednosti

koncentracija u zraku unutar normi za granične vrijednosti

izloženosti na radu.

Individualne mjere zaštite

Higijenske mjere

Rukovati u skladu s važećom industrijskom higijenom i

sigurnosnom praksom. Skinuti i oprati kontaminiranu odjeću prije

ponovnog korištenja. Nakon rukovanja temeljito oprati lice, ruke i

izloženu kožu. Osigurati odgovarajući prostor za brzo namakanje

ili ispiranje očiju i tijela u slučaju kontakta ili prskanja opasnim

kemikalijama

Zaštita očiju/lica (EN 166)

Zaštitne naočale

Stitnik za lice

Zaštita ruku (EN 374)

Preporučujemo preventivnu zaštitu kože

Rukavice

Nitrilna guma

Butilna guma

Vrijeme prodiranja: 1-4 sata

Minimalna debljina za butil gumu 0.7 za nitrilnu gumu 0.4 ili

ekvivalent (molimo pogledajte rukavice proizvođač / distributer za

savjet).

U slučaju bilo kakvih znakova razgradnje rukavica ili kemijskog

prodiranja kroz rukavice treba ih ukloniti i zamijeniti novim.

Zaštita kože i tijela (EN

Osobna zaštitna oprema sastoji se od: odgovarajućih zaštitnih

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

6 / 12

14605)

rukavica, sigurnosnih naočala i zaštitne odjeće

Zaštita organa za disanje

(EN 143, 14387)

Nije potrebna ako su koncentracije ispod GVI vrijednosti Koristiti

certificiranuzaštitnu opremu za disanje koja prati EU zahtjeve

(89/656/EEZ, 89/686/EEZ) ili slično kada se respiratorni rizici ne

mogu izbjeći ili ograničiti tehničkim mjerama kolektivne zaštite ili

mjerama, metodama i postupcima organizacije rada.

Nadzor nad zaštitom okoliša

Opći savjeti

: Osigurajte okolicu mjesta pohrane.

ODJELJAK 9. FIZIKALNA I KEMIJSKA SVOJSTVA

9.1 Informacije o osnovnim fizikalnim i kemijskim svojstvima

Agregatno stanje

: tekućina

Boja

: Bezbojno

Miris

: bez mirisa

13.0 - 13.9, 100 %

Plamište

Nije primjenjivo

Prag osjetljivosti mirisa

Ne može se primijeniti i /ili odrediti iz mješavine

Točka topljenja/Točka

topljenja

Ne može se primijeniti i /ili odrediti iz mješavine

Početna točka vrenja i

raspon vrenja

Ne može se primijeniti i /ili odrediti iz mješavine

Hlapivost

Ne može se primijeniti i /ili odrediti iz mješavine

Zapaljivost (kruta tvar, plin)

Ne može se primijeniti i /ili odrediti iz mješavine

Gornja granica

eksplozivnosti

Ne može se primijeniti i /ili odrediti iz mješavine

Donja granica eksplozivnosti

Ne može se primijeniti i /ili odrediti iz mješavine

Tlak pare

Ne može se primijeniti i /ili odrediti iz mješavine

Relativna gustoća pare

Ne može se primijeniti i /ili odrediti iz mješavine

Relativna gustoća

1.25 - 1.28

Topljivost u vodi

topivo

Topivost u drugim

sredstvima za otapanje

Ne može se primijeniti i /ili odrediti iz mješavine

Koeficijent raspodjele n-

oktanol/voda

Ne može se primijeniti i /ili odrediti iz mješavine

Temperatura

samozapaljenja

Ne može se primijeniti i /ili odrediti iz mješavine

Termička razgradnja

Ne može se primijeniti i /ili odrediti iz mješavine

Viskoznost, kinematička

Ne može se primijeniti i /ili odrediti iz mješavine

Eksplozivna svojstva

Ne može se primijeniti i /ili odrediti iz mješavine

Oksidirajuća svojstva

Tvar ili mješavina nije klasificirana kao oksidirajuća.

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

7 / 12

9.2 Ostali podaci

Ne može se primijeniti i /ili odrediti iz mješavine

ODJELJAK 10. STABILNOST I REAKTIVNOST

10.1 Reaktivnost

Nisu poznate opasne reakcije u uvjetima uobičajene uporabe.

10.2 Kemijska stabilnost

Stabilno u normalnim uvjetima.

10.3 Mogućnost opasnih reakcija

Nisu poznate opasne reakcije u uvjetima uobičajene uporabe.

10.4 Uvjeti koje treba izbjegavati

Nisu poznati.

10.5 Inkompatibilni materijali

Kiseline

10.6 Opasni proizvodi raspadanja

Produkti raspadanja mogu uključivati sljedeće materijale:

ugljikovi oksidi

Dušikovi oksidi (NOx)

sumporni oksidi

Fosforovi oksidi

ODJELJAK 11. TOKSIKOLOŠKE INFORMACIJE

11.1 Informacije o toksikološkim učincima

Informacije o vjerojatnim

načinima izlaganja

Inhalacija, Dodir s očima, Dodir s kožom

Proizvod

Akutna oralna toksičnost

: Nema raspoloživih podataka o ovom proizvodu.

Akutna toksičnost pri

udisanju

: Nema raspoloživih podataka o ovom proizvodu.

Akutna kožna toksičnost

: Nema raspoloživih podataka o ovom proizvodu.

Nadraživanje i nagrizanje

kože

: Nema raspoloživih podataka o ovom proizvodu.

Ozbiljno oštećenje

oka/nadraživanje oka

: Nema raspoloživih podataka o ovom proizvodu.

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

8 / 12

Senzibilizacija kože ili dišnih

puteva

: Nema raspoloživih podataka o ovom proizvodu.

Karcinogenost

: Nema raspoloživih podataka o ovom proizvodu.

Učinci na razmnožavanje

: Nema raspoloživih podataka o ovom proizvodu.

Mutagenost zametnih stanica

: Nema raspoloživih podataka o ovom proizvodu.

Teratogenost

: Nema raspoloživih podataka o ovom proizvodu.

Specifična toksičnost za

ciljne organe/sustavna

toksičnost (jednokratna

izloženost)

: Nema raspoloživih podataka o ovom proizvodu.

Specifična toksičnost za

ciljne organe/sustavna

toksičnost (opetovana

izloženost)

: Nema raspoloživih podataka o ovom proizvodu.

Aspiracijska toksičnost

: Nema raspoloživih podataka o ovom proizvodu.

Sastojci

Akutna oralna toksičnost

: alanine, n,n-bis(carboxymethyl)-, trisodium salt

LD50 Štakor: > 2,000 mg/kg

Sastojci

Akutna kožna toksičnost

: alanine, n,n-bis(carboxymethyl)-, trisodium salt

LD50 Štakor: > 4,000 mg/kg

Potencijalno djelovanje na zdravlje

Oči

Uzrokuje teške ozljede oka.

Koža

Prouzrokuje teške opekline kože.

Gutanje

Prouzrokuje opekline probavnog trakta.

Inhalacija

Može prouzrokovati nadraživanje nosa, grla i pluća.

Kronično izlaganje

Zdravstvena oštećenja nisu poznata, niti su za očekivati pri

normalnoj upotrebi.

Iskustvo s izlaganjem ljudi

Dodir s očima

Crvenilo, Bol, Nagrizanje

Dodir s kožom

Crvenilo, Bol, Nagrizanje

Gutanje

Nagrizanje, Bolovi u trbuhu

Inhalacija

Nadraženost dišnih puteva, Kašalj

ODJELJAK 12. EKOLOŠKE INFORMACIJE

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

9 / 12

12.1 Ekotoksičnost

Utjecaj na okoliš

Proizvod nema poznatih ekotoksičnih posljedica.

Proizvod

Otrovnost za ribe

: Nema raspoloživih podataka

Toksično za daphnia i ostale

vodene beskičmenjake.

: Nema raspoloživih podataka

Otrovnost za alge

: Nema raspoloživih podataka

Sastojci

Otrovnost za ribe

: alanine, n,n-bis(carboxymethyl)-, trisodium salt

96 h LC50 Ribe: > 200 mg/l

Sastojci

Toksično za daphnia i ostale

vodene beskičmenjake.

: sodium hydroxide

48 h EC50: 40 mg/l

12.2 Postojanost i razgradivost

Proizvod

Nema raspoloživih podataka

Sastojci

Biorazgradljivost

sodium hydroxide

Rezultat: Nije primjenjivo - anorganski

alanine, n,n-bis(carboxymethyl)-, trisodium salt

Rezultat: Biološki vrlo razgradljivo.

12.3 Bioakumulacijski potencijal

Nema raspoloživih podataka

12.4 Pokretljivost u tlu

Nema raspoloživih podataka

12.5 Rezultati procjene PBT i vPvB svojstava

Proizvod

Ocjena

Ova tvar/smjesa ne sadrži komponente koje se smatraju

postojanim, bioakumulirajućima i toksičnima (PBT), ili jako

postojanim i jako bioakumulirajućima (VPvB) na razinama od

0.1% ili više.

12.6 Ostali štetni učinci

Nema raspoloživih podataka

ODJELJAK 13. ZBRINJAVANJE

Odlažite u skladu s europskim direktivama o otpadu i opasnom otpadu.Kodove otpada bi trebao

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

10 / 12

odrediti korisnik, po mogućnosti u dogovoru s nadležnim organima za zbrinjavanje otpada.

13.1 Metode postupanja s otpadom

Proizvod

: Uvijek kada je moguće se preferira recikliranje od odlaganja ili

spaljivanja. Ukoliko se ne može sprovesti recikliranje, odlagati u

skladu s lokalnim uredbama. Otpad odlažite na ovlaštena

odlagališta namijenjena toj svrsi.

Kontaminirana ambalaža

: Odlagati kao neupotrijebljen proizvod. Prazne spremnike treba

dostaviti ovlaštenoj osobi za postupanje s otpadom na recikliranje

ili odlaganje. Prazni spremnici se ne smiju ponovno upotrebljavati.

Odložite u skladu s mjesnim, državnim i federalnim propisima.

Smjernice za izbor koda za

otpad

: Inorganic wastes containing dangerous substances. If this product

is used in any further processes, the final user must redefine and

assign the most appropriate European Waste Catalogue Code. It

is the responsibility of the waste generator to determine the

toxicity and physical properties of the material generated to

determine the proper waste identification and disposal methods in

compliance with applicable European (EU Directive 2008/98/EC)

and local regulations.

ODJELJAK 14. INFORMACIJE O PRIJEVOZU

Pošiljatelj je odgovoran osigurati da pakiranje, etiketiranje i obilježavanje je u skladu sa odabranim

načinom prijevoza.

Kopneni prijevoz (ADR/ADN/RID)

14.1 UN broj

1824

14.2 Pravilno otpremno ime

prema UN-u

NATRIJEV HIDROKSID OTOPINA

14.3 Razred(i) opasnosti pri

prijevozu

14.4 Skupina pakiranja

14.5 Opasnosti za okoliš

14.6 Posebne mjere opreza

za korisnike

Nijedan

Zračni prijevoz (IATA)

14.1 UN broj

1824

14.2 Pravilno otpremno ime

prema UN-u

Sodium hydroxide solution

14.3 Razred(i) opasnosti pri

prijevozu

14.4 Skupina pakiranja

14.5 Opasnosti za okoliš

14.6 Posebne mjere opreza

za korisnike

Nijedan

Morski prijevoz (IMDG/IMO)

14.1 UN broj

1824

14.2 Pravilno otpremno ime

prema UN-u

SODIUM HYDROXIDE SOLUTION

14.3 Razred(i) opasnosti pri

prijevozu

14.4 Skupina pakiranja

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

11 / 12

14.5 Opasnosti za okoliš

14.6 Posebne mjere opreza

za korisnike

Nijedan

14.7 Prijevoz u rasutom

stanju prema aneksu II

konvencije MARPOL 73/78 i

IBC kodu

Nije primjenjivo

ODJELJAK 15. INFORMACIJE O PROPISIMA

15.1 Propisi u području sigurnosti, zdravlja i okoliša/posebno zakonodavstvo za tvar ili smjesu

sukladno Uredbi o

deterdžentima EZ 648/2004

manje od 5%: Polikarboksilati

Nacionalni propisi

Obratiti pažnju na Direktivu 94/33/EZ o zaštiti mladih ljudi na poslu.

Druge uredbe

Zakon o kemikalijama, Pravilnik o dokumentaciji za ocjenu aktivne

tvari u biocidnim pripravcima, dokumentaciji za ocjenu biocidnih

pripravaka, postupcima ocjenjivanja biocidnih pripravaka i njihove

uporabe te o vrstama biocidnih pripravaka s njihovim opisima i

jedinstvenim načelima za ocjenjivanje biocidnih pripravaka,

Pravilnik o popisu aktivnih tvari u biocidnim pripravcima, Pravilnik

o popisu postojećih aktivnih tvari dopuštenih u biocidnim

pripravcima, Pravilnik o popisu postojećih aktivnih tvari koje nisu

dopuštene u biocidnim pripravcima, Pravilnik o graničnim

vrijednostima izloženosti opasnim tvarima pri radu i o biološkim

graničnim vrijednostima, Zakon o zaštiti na radu, Zakon o

prijevozu opasnih tvari, Pravilnik o deterdžentima.

15.2 Procjena sigurnosti kemikalija

Ovaj proizvod sadrži supstance za koje su Procjene sigurnosti kemikalija još uvijek neophodne.

ODJELJAK 16. OSTALE INFORMACIJE

Cjelovit tekst H-izjava

H290

Može nagrizati metale.

H314

Uzrokuje teške opekline kože i ozljede oka.

H315

Nadražuje kožu.

H319

Uzrokuje jako nadraživanje oka.

Cjelovit tekst ostalih skraćenica

ADN - Europskog sporazuma o međunarodnom prijevozu opasnih tvari unutarnjim plovnim

putovima; ADR - Europski sporazum o međunarodnom cestovnom prijevozu opasnih tvari; AICS -

Australijski popis kemijskih tvari; ASTM - Američko društvo za ispitivanje materijala; bw - Tjelesna

masa; CLP - Klasifikacija uredbe o označavanju ambalaže; Uredba (EC) br. 1272/2008; CMR -

Kancerogen,

mutagen

reproduktivni

otrov;

Standard

Njemačkog

instituta

standardizaciju; DSL - Popis domaćih tvari (Kanada); ECHA - Europska agencija za kemikalije;

EC-Number - Broj Europske zajednice; ECx - Koncentracija povezana s x% odgovorom; ELx -

Stopa učitavanja povezana s x% odgovorom; EmS - Hitni raspored; ENCS - Postojeće i nove

kemijske tvari (Japan); ErCx - Koncentracija povezana s x% stopom rasta odgovora; GHS -

SIGURNOSNO -TEHNIČKI LIST

sukladno Uredbi (EZ) br. 1907/2006

Trump Event (Special)

113293E

12 / 12

Globalno usklađen sustav; GLP - Dobra laboratorijska praksa; IARC - Međunarodna agencija za

istraživanje raka; IATA - Međunarodna udruga za zračni prijevoz; IBC - Međunarodni kodeks za

gradnju i opremanje brodova koji prevoze opasne kemikalije u rasutom stanju; IC50 - Pola

maksimalne koncentracije inhibitora; ICAO - Međunarodna organizacija za civilno zrakoplovstvo;

IECSC - Popis postojećih kemijskih tvari u Kini; IMDG - Međunarodni pomorski pravilnik za

prijevoz opasnih tvari; IMO - Međunarodna pomorska organizacija; ISHL - Zakon o industrijskoj

sigurnosti i zdravlju (Japan); ISO - Međunarodna organizacija za standardizaciju; KECI - Popis

postojećih kemikalija Koreje; LC50 - Smrtonosna koncentracija za 50% testirane populacije; LD50

Smrtonosna

doza

testirane

populacije

(Srednja

smrtonosna

doza);

MARPOL

Međunarodna konvencija o sprječavanju onečišćenja s brodova; n.o.s.

- Koji nije definiran

drugačije;

NO(A)EC

Nije

promatrana

(negativan)

koncentracija

učinka;

NO(A)EL

Nije

promatrano (negativan) razina učinka; NOELR - Nije primjetan učinak stope učitavanja; NZIoC -

Popis kemikalija Novog Zelanda; OECD - Organizacija za ekonomsku suradnju i razvoj; OPPTS -

Ured kemijske sigurnosti i sprječavanja onečišćenja; PBT - Postojana, bioakumulativna i otrovna

tvar; PICCS - Popis kemikalija i kemijskih tvari Filipina; (Q)SAR - (Kvantitativno) Struktura

aktivnosti odnosa; REACH - Uredba (EZ) br. 1907/2006 Europskog parlamenta i Vijeća o

registriranju, ocjenjivanju, odobravanju i ograničavanju kemikalija; RID - Propisi o međunarodnom

prijevozu opasnih tvari željeznicom; SADT - Samoubrzanje temperature raspadanja; SDS -

Sigurnosni podatkovni list; TCSI - Popis kemijskih tvari Tajvana; TRGS - Tehnička pravila za

opasne tvari; TSCA - Zakon o kontroli otrovnih tvari (SAD); UN - Ujedinjene nacije; vPvB - Vrlo

postojani i vrlo bioakumulacijski

Pripremio

Poslovi vezani za zakonske propise

Brojevi navedeni u sigurnosnim listama (MSDS) dani su u obliku: 1,000 ,000 = 1 miljun and 1,000

= 1 tisuća. 0.1 = 1 destinka i 0.001 = 1 tisucinka.

PREPRAVLJENI PODACI: Znatne promjene zdravstvenih podataka za ovu reviziju su obilježene

na lijevoj margini MSDS-a.

Podaci u ovom sigurnosno-tehničkom listu odgovaraju našim saznanjima, informacijama i

uvjerenjima na dan izdavanja istog. Informacije sadržane u njemu, dane su samo kao smjernice

za sigurno rukovanje, upotrebu, postupanje, skladištenje, prijevoz i odlaganje otpada i nisu

garancija ili specifikacija kvalitete. Podaci se odnose isključivo na navedenu tvar/smjesu i nisu

nužno važeći za istu tu tvar/smjesu ukoliko se ista koristi sa bilo kojim drugim tvarima ili u bilo

kojem drugom postupku koji nije specificiran u tekstu.

  • Informativni letak za ovaj proizvod trenutno nije dostupan, možete poslati zahtjev na našu službu za korisnike, a mi ćemo vas obavijestiti čim smo u mogućnosti da ga dobiju.

    Zatražite informativni letak za javnost.



  • Dokumenti u drugim jezicima dostupne ovdje

15-11-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed new steps to protect youth by preventing access to flavored tobacco products and banning menthol in cigarettes

Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed new steps to protect youth by preventing access to flavored tobacco products and banning menthol in cigarettes

Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed new steps to protect youth by preventing access to flavored tobacco products and banning menthol in cigarettes

FDA - U.S. Food and Drug Administration

15-11-2018

Assessment of genetically modified LLCotton25 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐010)

Assessment of genetically modified LLCotton25 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐010)

Published on: Wed, 14 Nov 2018 Following the submission of application EFSA‐GMO‐RX‐010 under Regulation (EC) No 1829/2003 from Bayer, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the herbicide‐tolerant genetically modified LLCotton25, for food and feed uses, import and processing, excluding cultivation within the EU. The d...

Europe - EFSA - European Food Safety Authority Publications

8-11-2018

Theme event on big data and medicine

Theme event on big data and medicine

The U.S. Food and Drug Administration, FDA, The European Medicines Agency, EMA, and Novo Nordisk are among the speakers when The Danish Medicines Agency on 20 November 2018 puts focus on big data and medicine under the event heading “From Big Data to Real World Evidence”.

Danish Medicines Agency

1-11-2018

Three research projects to increase our knowledge of medicinal cannabis

Three research projects to increase our knowledge of medicinal cannabis

Three projects have just been granted funds to give us more knowledge about the efficacy of medicinal cannabis. A total of DKK 5 million have been distributed of the funds that were appropriated by the negotiating parliamentary parties under the special funds agreement 2018-2021 to accumulate scientific knowledge of medicinal cannabis.

Danish Medicines Agency

24-10-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recove

Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recove

The SUPPORT Act grants FDA additional authorities to meaningfully advance efforts to combat the crisis of opioid addiction plaguing our nation.

FDA - U.S. Food and Drug Administration

24-10-2018

Sirob Imports, Inc. Issues Recall Due to Elevated Lead in Spices

Sirob Imports, Inc. Issues Recall Due to Elevated Lead in Spices

Sirob Imports, Inc of Lindenhurst, NY is recalling, Corrado, Orlando Imports, Nouri’s Syrian Bakery, Mediterranean Specialty Foods Brand and Butera Fruit Market Curry Powder because it contains elevated levels of lead.

FDA - U.S. Food and Drug Administration

18-10-2018

Trump Administration Launches “Winning on Reducing Food Waste” Initiative

Trump Administration Launches “Winning on Reducing Food Waste” Initiative

The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the "Winning on Reducing Food Waste" initiative.

FDA - U.S. Food and Drug Administration

16-10-2018

Brexit: Two-year implementation period for name and address changes

Brexit: Two-year implementation period for name and address changes

During an implementation period of maximum two years, it will be permitted to sell released packs on which a UK marketing authorisation holder or a representative is indicted as well as packs on which an EEA marketing authorisation holder or a representative is indicated for the concerned D.Sp.No. (Danish speciality number).

Danish Medicines Agency

22-9-2018

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Published on: Fri, 21 Sep 2018 00:00:00 +0200 The GMO Panel has previously assessed genetically modified (GM) soybean BPS‐CV127‐9. This soybean was found to be as safe and nutritious as its conventional counterpart and commercial soybean varieties with respect to potential effects on human and animal health and the environment in the context of its intended uses. On 16 February 2018, European Commission requested EFSA to analyse new nucleic acid sequencing data and updated bioinformatics data for GM soy...

Europe - EFSA - European Food Safety Authority Publications

20-9-2018

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Published on: Wed, 19 Sep 2018 00:00:00 +0200 The third Joint Meeting of the ECDC's Food‐ and Waterborne Disease and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network was held on 16 and 17 October 2017 in Parma. The meeting was constructed around the principle of ‘One health approach to collaborative response to foodborne disease outbreaks in EU/EEA’ and served as an opportunity for public health authorities and food safety/veterinary authorities to meet and exchange information on the...

Europe - EFSA - European Food Safety Authority Publications

18-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids.

FDA - U.S. Food and Drug Administration

18-9-2018

FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids

FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids

FDA launched new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids.

FDA - U.S. Food and Drug Administration

17-8-2018

Seabreeze International Corp. recalls certain Smart ThermafloTM Heaters

Seabreeze International Corp. recalls certain Smart ThermafloTM Heaters

In the event of a fault, the safety cut-offs may not operate and allow the heater to rapidly overheat, posing a fire hazard.

Health Canada

16-8-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on significant public health value and cost savings resulting from the agency’s youth smoking prevention campaign

Statement from FDA Commissioner Scott Gottlieb, M.D., on significant public health value and cost savings resulting from the agency’s youth smoking prevention campaign

A cost-effectiveness analysis of the FDA’s “The Real Cost” youth smoking prevention campaign shows it has resulted in savings of more than $31 billion for youth, their families and society at large.

FDA - U.S. Food and Drug Administration

24-7-2018

Orphan designation:  Itraconazole,  for the: Prevention of invasive aspergillosis

Orphan designation: Itraconazole, for the: Prevention of invasive aspergillosis

Europe - EMA - European Medicines Agency

18-7-2018

FDA Approves NexGard for prevention of infections that cause Lyme disease in dogs

FDA Approves NexGard for prevention of infections that cause Lyme disease in dogs

FDA has approved NexGard (afoxolaner), a chewable tablet administered once monthly to dogs, for the prevention of Borrelia burgdorferi (B. burgdorferi) infections by killing Black-legged ticks (Ixodes scapularis), which carry the bacterium.

FDA - U.S. Food and Drug Administration

18-7-2018

FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, is investigating a multi-state outbreak of Salmonella Sandiego illnesses linked to Spring Pasta Salad sold at Hy-Vee locations in Iowa, Illinois, Kansas, Minnesota, Missouri, Nebraska, South Dakota, and Wisconsin.

FDA - U.S. Food and Drug Administration

18-7-2018

&quot;Anti-pollution&quot; masks: not enough data to demonstrate a health benefit and justify recommending their use

&quot;Anti-pollution&quot; masks: not enough data to demonstrate a health benefit and justify recommending their use

In a context where prevention of ambient air pollution is a real public health issue, questions are regularly asked about the value of recommending that the population wear personal protective equipment. This led ANSES to assess the potential health benefits of wearing "anti-pollution" masks. Its expert appraisal revealed a lack of data demonstrating a health benefit. To reduce the health impacts associated with ambient air pollution, the Agency reiterates the importance of prioritising action at the sou...

France - Agence Nationale du Médicament Vétérinaire

18-7-2018

Blokhuis: jaarlijkse subsidie voor 113Zelfmoordpreventie omhoog naar 5,4 miljoen

Blokhuis: jaarlijkse subsidie voor 113Zelfmoordpreventie omhoog naar 5,4 miljoen

Staatssecretaris Paul Blokhuis (VWS) wil het aantal zelfmoorden en zelfmoordpogingen terugdringen. Om dat te bereiken geeft hij structureel 2 miljoen per jaar extra instellingssubsidie aan 113Zelfmoordpreventie. Het jaarlijkse budget van de organisatie gaat daarmee fors omhoog, van 3,4 miljoen naar 5,4 miljoen euro. Daarnaast zijn er extra middelen voor andere lopende activiteiten zoals de lokale aanpakken suïcidepreventie en onderzoek. In totaal is daar 15 miljoen mee gemoeid.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

13-7-2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.

FDA - U.S. Food and Drug Administration

10-7-2018

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

PrEP wordt binnen een onderzoekssetting voor een periode van vijf jaar verstrekt aan de hoogrisicogroep van mannen die seks hebben met mannen (MSM). Dat heeft minister Bruno Bruins (Medische Zorg) vandaag bekend gemaakt. Op basis van schattingen van het RIVM zullen ongeveer 6500 mannen hiervan gebruik gaan maken en kunnen hiermee  250 hiv-infecties per jaar worden voorkomen. Voor gebruikers gaat een eigen bijdrage gelden van maximaal 25%, dat komt overeen met ongeveer 12 euro per maand. Ook wordt hen gev...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

28-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Being able to identify outbreaks is key to being able to take quick action to prevent additional illnesses and find the source of the contamination. In recent years, the FDA and the Centers for Disease Control and Prevention (CDC) have advanced new tools that make it easier and faster to identify outbreaks of human illness and to link them back to the food source that is the culprit responsible for the illnesses. But our improved ability to spot outbreaks has also caused some to question whether we are e...

FDA - U.S. Food and Drug Administration

26-6-2018

Blokhuis: 1 miljoen euro voor Caribisch Preventie- en Sportakkoord

Blokhuis: 1 miljoen euro voor Caribisch Preventie- en Sportakkoord

Voor Caribisch Nederland is er met ingang van 2019 jaarlijks zo’n 1 miljoen euro extra beschikbaar om roken, overgewicht en problematisch alcoholgebruik tegen te gaan en gezond eten, bewegen en sporten te bevorderen. Dat heeft staatssecretaris Paul Blokhuis (VWS) bekend gemaakt bij zijn bezoeken aan Saba en Sint Eustatius.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

21-6-2018

Staatssecretaris Blokhuis naar Caribisch gebied over zorg en preventie

Staatssecretaris Blokhuis naar Caribisch gebied over zorg en preventie

Staatssecretaris Paul Blokhuis (VWS) bezoekt vanaf donderdag 21 juni tot en met woensdag 27 juni 2018 een serie zorginstellingen op de bovenwindse eilanden Saba en Sint Eustatius. Alle gezondheidszorg, ouderenzorg en jeugdzorg in Caribisch Nederland vallen onder de verantwoordelijkheid van de staatssecretaris van VWS.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

16-6-2018

FDA Investigates Multistate Outbreak of Cyclospora illnesses linked to Del Monte Vegetable Trays

FDA Investigates Multistate Outbreak of Cyclospora illnesses linked to Del Monte Vegetable Trays

The U.S. Food and Drug Administration (FDA) along with the Centers for Disease Control and Prevention (CDC) and state and local officials have been investigating a cluster of cyclosporiasis illnesses associated with recalled Del Monte vegetable trays from Kwik Trip/Kwik Star locations in the United States.

FDA - U.S. Food and Drug Administration

15-6-2018

Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events Reported After Receiving Eye Injections

Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events Reported After Receiving Eye Injections

At least 43 patient reported adverse event after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients reportedly experienced various symptoms, including vision impairment, poor night vision, loss of color perception, and significant reductions in best-corrected visual acuity and visual fields. FDA identified multiple substances in Guardian’s product, including poloxamer 407 and poloxamer 407 degradants. FDA prepared i...

FDA - U.S. Food and Drug Administration

15-6-2018

FDA Investigating Multistate Outbreak of Salmonella Mbandaka Infections Likely Linked to Kellogg’s Honey Smacks Cereal

FDA Investigating Multistate Outbreak of Salmonella Mbandaka Infections Likely Linked to Kellogg’s Honey Smacks Cereal

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, are investigating a multistate outbreak of Salmonella Mbandaka illnesses that may be linked to Kellogg’s Honey Smacks cereal.

FDA - U.S. Food and Drug Administration

14-6-2018

ANSES consolidates its presence in Boulogne-sur-Mer!

ANSES consolidates its presence in Boulogne-sur-Mer!

Centrally located in the port of Boulogne-sur-Mer, the Laboratory for Food Safety's site specialising in fishery and aquaculture products is expanding! This extension, financed jointly by the Hauts-de-France Region and the local community, underlines ANSES's scientific investment in Boulogne-sur-Mer and is fully consistent with regional research dynamics for the quality and safety of aquatic products.

France - Agence Nationale du Médicament Vétérinaire

14-6-2018

FDA Releases FSMA Draft Guidance on the Supply-Chain Program Preventive Control for Animal Food

FDA Releases FSMA Draft Guidance on the Supply-Chain Program Preventive Control for Animal Food

FDA issued draft guidance to help animal food facilities needing a supply-chain program meet those requirements under the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals rule.

FDA - U.S. Food and Drug Administration

9-6-2018

FDA Investigating Multistate Outbreak of Salmonella Adelaide Infections Linked to Pre-Cut Melons

FDA Investigating Multistate Outbreak of Salmonella Adelaide Infections Linked to Pre-Cut Melons

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, are investigating a multistate outbreak of Salmonella Adelaide illnesses that may be linked to cut melons.

FDA - U.S. Food and Drug Administration

7-6-2018

Minister Bruno Bruins (Sport) opent Special Olympics 2018

Minister Bruno Bruins (Sport) opent Special Olympics 2018

Dit weekend worden in de Achterhoek de Special Olympics Nationale Spelen gehouden. Meer dan 2000 sporters met een verstandelijke beperking gaan de strijd aan in 20 takken van sport. Sportminister Bruno Bruins zal de Spelen vrijdagavond officieel openen tijdens een feestelijke ceremonie in Stadion de Vijverberg in Doetinchem. Bruno Bruins: ‘Sporten is gezond en vooral leuk. Ik vind het belangrijk dat iedereen kan sporten en er lol aan beleeft. Dat is ook een belangrijk onderdeel van het sportakkoord dat i...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

7-6-2018

Prevent Heartworms in Dogs, Cats, and Ferrets Year-Round

Prevent Heartworms in Dogs, Cats, and Ferrets Year-Round

Heartworm disease can be fatal to pets, but it is also preventable. Learn more about the dangers of heartworm disease and the importance of year-round prevention.

FDA - U.S. Food and Drug Administration

6-6-2018

National Network for the Monitoring and Prevention of Occupational Diseases: new data published on cancers of occupational origin

National Network for the Monitoring and Prevention of Occupational Diseases: new data published on cancers of occupational origin

At the 35th French occupational medicine and health congress (CNMST) held in Marseille from 5 to 8 June 2018, ANSES presented for the very first time data on cancers of occupational origin collected by the National Network for Monitoring and Prevention of Occupational Diseases (RNV3P) coordinated by the Agency. These data are used to build up a comprehensive picture of the cancers associated with occupational exposure situations, in order toidentify the industry sectors and situations most at risk, with ...

France - Agence Nationale du Médicament Vétérinaire

1-6-2018

FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files

FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files

FDA Adverse Event Reporting System (FAERS) - Quarterly Data Extract (QDE): The Quarterly Data Extract files, contain raw data extracted from the FAERS database for the indicated time ranges (not cumulative), in ASCII or SGML formats.

FDA - U.S. Food and Drug Administration

1-6-2018

FDA Adverse Event Reporting System (FAERS) Public Dashboard

FDA Adverse Event Reporting System (FAERS) Public Dashboard

Four FAERS summary statistics reports updated with data through December 31, 2013.

FDA - U.S. Food and Drug Administration

1-6-2018

Specialized Bicycle Components Canada, Inc. recalls Bicycles with Stout Crankarms

Specialized Bicycle Components Canada, Inc. recalls Bicycles with Stout Crankarms

The crankarm can disengage and cause the rider to lose control, posing fall and injury hazards.

Health Canada

30-5-2018

12 applications for allocation of special funds related to medicinal cannabis

12 applications for allocation of special funds related to medicinal cannabis

The application deadline for the second allocation of special funds for accumulation of scientific knowledge in regard to the medicinal cannabis pilot programme has now expired. The Danish Medicines Agency received 12 applications.

Danish Medicines Agency

24-5-2018

Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

Ticks and Lyme Disease: Symptoms, Treatment, and Prevention

Lyme disease is on the rise. How can you prevent it? What are the symptoms, and what should you do if you think you or your pet have it?

FDA - U.S. Food and Drug Administration

23-5-2018

The FDA is Seeking Input on the Evaluation of Approaches to Demonstrate Effectiveness of Heartworm Preventatives for Dogs

The FDA is Seeking Input on the Evaluation of Approaches to Demonstrate Effectiveness of Heartworm Preventatives for Dogs

FDA’s CVM is evaluating the design of studies intended to support the standard of effectiveness for new animal drugs to prevent heartworm disease in dogs. The FDA is requesting public input on evaluating these products to assist in the potential development of alternative study designs.

FDA - U.S. Food and Drug Administration

18-5-2018

FDA approves novel preventive treatment for migraine

FDA approves novel preventive treatment for migraine

FDA approves Aimovig for the preventive treatment of migraine. Aimovig works by blocking the activity of a molecule that is involved in migraine attacks.

FDA - U.S. Food and Drug Administration

11-5-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices

Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices

FDA - U.S. Food and Drug Administration

10-5-2018

FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan

FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan

FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan

FDA - U.S. Food and Drug Administration

21-9-2018

Scientific guideline:  Reflection paper on resistance in ectoparasites, draft: consultation open

Scientific guideline: Reflection paper on resistance in ectoparasites, draft: consultation open

The Committee adopted a new draft reflection paper on ectoparasitic resistance (EMA/CVMP/EWP/310225/2014) for a 11-month period of public consultation. The reflection paper aims to give an overview of the currently known resistance situation in ectoparasites to active substances used in veterinary medicinal products with a special focus on Europe, and to provide a review of the current knowledge on resistance mechanisms.

Europe - EMA - European Medicines Agency

19-9-2018

 Important medical event terms list version 21.0 (IME-List)

Important medical event terms list version 21.0 (IME-List)

Europe - EMA - European Medicines Agency

18-9-2018

As part of FDA’s ongoing efforts to reduce the enormous public health burden of tobacco use, the agency is unveiling a new e-cigarette prevention campaign aimed at educating youth about the potential dangers and health impacts caused by e-cigarette use. h

As part of FDA’s ongoing efforts to reduce the enormous public health burden of tobacco use, the agency is unveiling a new e-cigarette prevention campaign aimed at educating youth about the potential dangers and health impacts caused by e-cigarette use. h

As part of FDA’s ongoing efforts to reduce the enormous public health burden of tobacco use, the agency is unveiling a new e-cigarette prevention campaign aimed at educating youth about the potential dangers and health impacts caused by e-cigarette use. https://cards.twitter.com/cards/2m2m96/68507 …

FDA - U.S. Food and Drug Administration

14-9-2018

#FDA MQSA: Mammography Facility Adverse Event and Action Report - September 13, 2018: Lakes Radiology II, Inc. Read the report here:  http://go.usa.gov/xPgTB  #MedicalDevice

#FDA MQSA: Mammography Facility Adverse Event and Action Report - September 13, 2018: Lakes Radiology II, Inc. Read the report here: http://go.usa.gov/xPgTB  #MedicalDevice

#FDA MQSA: Mammography Facility Adverse Event and Action Report - September 13, 2018: Lakes Radiology II, Inc. Read the report here: http://go.usa.gov/xPgTB  #MedicalDevice

FDA - U.S. Food and Drug Administration

12-9-2018

 Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

This information day will update participants on the Agency’s medicine risk management activities and provide advice to marketing authorisation holders and applicants on drafting a risk management plan (RMP) in view of the full implementation of the second revision of the RMP template after the transitional period has elapsed. It will also provide an opportunity for an exchange of experiences with this template between regulators and industry. A dedicated session will discuss the streamlining of safety s...

Europe - EMA - European Medicines Agency

15-8-2018

Scientific guideline:  Draft guideline on quality of herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

Scientific guideline: Draft guideline on quality of herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

This document intends to cover the general quality aspects of herbal medicinal products for human and veterinary use, including traditional herbal medicinal products for human use. It describes the special problems of herbal medicinal products and the differences between medicinal products containing chemically defined active substances.

Europe - EMA - European Medicines Agency

13-8-2018

IMDRF consultation: Terminologies for categorised adverse event reporting

IMDRF consultation: Terminologies for categorised adverse event reporting

The IMDRF is seeking comments on a proposed document and its annexes

Therapeutic Goods Administration - Australia

10-8-2018

Vyaire Medical, Inc. Recalls AirLife Resuscitation Devices Due to Manufacturing Error Preventing Oxygen Delivery  https://go.usa.gov/xUHgr  #fda #medicaldevice

Vyaire Medical, Inc. Recalls AirLife Resuscitation Devices Due to Manufacturing Error Preventing Oxygen Delivery https://go.usa.gov/xUHgr  #fda #medicaldevice

Vyaire Medical, Inc. Recalls AirLife Resuscitation Devices Due to Manufacturing Error Preventing Oxygen Delivery https://go.usa.gov/xUHgr  #fda #medicaldevice

FDA - U.S. Food and Drug Administration

8-8-2018

The FDA’s Fresh Empire campaign illustrates tobacco prevention messages to multicultural youth in a novel and attention-grabbing way. 

Watch the new ad encouraging teens to live tobacco free: https://www.youtube.com/watch?v=6iBAMnU96UY …

The FDA’s Fresh Empire campaign illustrates tobacco prevention messages to multicultural youth in a novel and attention-grabbing way. Watch the new ad encouraging teens to live tobacco free: https://www.youtube.com/watch?v=6iBAMnU96UY …

The FDA’s Fresh Empire campaign illustrates tobacco prevention messages to multicultural youth in a novel and attention-grabbing way. Watch the new ad encouraging teens to live tobacco free: https://www.youtube.com/watch?v=6iBAMnU96UY …

FDA - U.S. Food and Drug Administration

2-8-2018

EU/3/18/2054 (Mallinckrodt Specialty Pharmaceuticals Ireland Limited)

EU/3/18/2054 (Mallinckrodt Specialty Pharmaceuticals Ireland Limited)

EU/3/18/2054 (Active substance: Tetracosactide) - Orphan designation - Commission Decision (2018)5286 of Thu, 02 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/043/18

Europe -DG Health and Food Safety

30-7-2018

Special Access Scheme online system

Special Access Scheme online system

Introduction of the Special Access Scheme online system

Therapeutic Goods Administration - Australia

22-7-2018

Once on market, #FDA monitors for safety issues by collecting adverse event reports  https://bit.ly/2mlhQ20 , reviewing published studies, ordering postmarket studies and inspecting facilities. We want to build on limits of these tools, as they don’t prov

Once on market, #FDA monitors for safety issues by collecting adverse event reports https://bit.ly/2mlhQ20 , reviewing published studies, ordering postmarket studies and inspecting facilities. We want to build on limits of these tools, as they don’t prov

Once on market, #FDA monitors for safety issues by collecting adverse event reports https://bit.ly/2mlhQ20 , reviewing published studies, ordering postmarket studies and inspecting facilities. We want to build on limits of these tools, as they don’t provide real-time information pic.twitter.com/WJMYVcAyoQ

FDA - U.S. Food and Drug Administration

18-7-2018

#ICYMI - According to @PAPATIENTSAFETY June 2018 report, the number of reported surgical fires has decreased since 2011.  Read more about preventing surgical fires here:  https://go.usa.gov/xU5zs  #FDA #MedicalDevice

#ICYMI - According to @PAPATIENTSAFETY June 2018 report, the number of reported surgical fires has decreased since 2011. Read more about preventing surgical fires here: https://go.usa.gov/xU5zs  #FDA #MedicalDevice

#ICYMI - According to @PAPATIENTSAFETY June 2018 report, the number of reported surgical fires has decreased since 2011. Read more about preventing surgical fires here: https://go.usa.gov/xU5zs  #FDA #MedicalDevice

FDA - U.S. Food and Drug Administration

9-7-2018

Scientific guideline:  Concept paper on the need to develop a reflection paper on development of medicinal products to prevent and treat acute kidney injury, draft: consultation open

Scientific guideline: Concept paper on the need to develop a reflection paper on development of medicinal products to prevent and treat acute kidney injury, draft: consultation open

The concept paper will include discussion of and recommendations for the requirements for evaluation and development of medicinal products for the prevention and/or treatment of acute kidney injury (AKI) and its long-term complications. Relevant topics for discussion include patient populations, endpoints, study methodology, and study duration.

Europe - EMA - European Medicines Agency

25-5-2018

Skin cancer is the most preventable type of cancer. Avoiding sunburn and overexposure to the sun's ultraviolet rays is key:  https://survivorship.cancer.gov/springboard/wellness/sun-safety … #dontfrydaypic.twitter.com/1vzXm28tQC

Skin cancer is the most preventable type of cancer. Avoiding sunburn and overexposure to the sun's ultraviolet rays is key: https://survivorship.cancer.gov/springboard/wellness/sun-safety … #dontfrydaypic.twitter.com/1vzXm28tQC

Skin cancer is the most preventable type of cancer. Avoiding sunburn and overexposure to the sun's ultraviolet rays is key: https://survivorship.cancer.gov/springboard/wellness/sun-safety … #dontfryday pic.twitter.com/1vzXm28tQC

FDA - U.S. Food and Drug Administration